Access to the oral and intravenous (IV) formulations were made possible by the efforts of the team at the Goodman Pediatric Formulations Centre of the CHU Sainte-Justine (GPFC), and is another important step towards greater access to child-friendly medicines in Canada.
Another success for the GPFC of the CHU Sainte-Justine: two formulations of levetiracetam are now available in canada and indicated for use in children
About the author: Andrea Gilpin
